Skip to content
January 29, 2023

Equity.Guru

Investment information for the new generation

Revive Therapeutics (RVV.C) – Investor Roundtable

Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public markets pitfalls.

Today, we focus on Revive Therapeutics, a pharmaceuticals company based out of Toronto, Canada, who is currently in Phase 3 clinical trials for its bucillamine Covid treatment, as well as developing psychedelic therapeutic solutions for aggressive breast cancer and treatment-resistant depression.

Enjoy!

 

Related Posts

More on

Leave a Reply

Your email address will not be published. Required fields are marked *